Immunome Inc. (IMNM) Announces Proposed $125M Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. SPY
3. CRWV
4. BAC
5. RKLB
6. BLK
7. RXRX
8. NOW
9. CAT
10. FMC

Go back to Immunome Inc. (IMNM) Announces Proposed $125M Share Offering

Immunome Announces Proposed Public Offering of Common Stock

January 29, 2025 4:27 PM EST

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Immunome) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $125.0 million of shares of its common stock. All of the shares are being offered by Immunome. In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.... More